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Abstract
Purpose This systematic review examined educational training interventions for healthcare professionals (HCPs) discussing 
genetic testing and risk for hereditary breast cancer. There was a particular focus on the presence, and content, of commu-
nication elements within these packages.
Methods Searches were run via CINAHL, EMBASE, PUBMED, and PsychInfo in February 2019 to identify training 
interventions available to HCPs with reference to communication skills. Studies were assessed for quality, with relevant 
intervention and outcome data extracted and synthesized. This review followed the Preferred Reporting Items for System-
atic Review and Meta-analyses (PRISMA) statement and was registered on the PROSPERO database (CRD42019124010).
Results Of 3,988 items, seven papers, two of which were linked, were eligible for inclusion. There was a mix of randomized 
and single arm studies with web-based and face-to-face interventions. Content included an overview of genetics, heredi-
tary and familial background, and recommended practice techniques. Outcomes focused on communication, self-efficacy, 
knowledge, and satisfaction. Interventions were designed for genetic counselors, physicians, primary care physicians (PCPs), 
medical students, and nurses. None of the papers featured oncologists or surgeons.
Conclusions This review revealed an overall lack of publications which evaluated interventions to assist HCPs discussing 
hereditary breast cancer risk and testing. Studies failed to operationalize which ‘communication skills’ they included, nor 
did they consistently report randomization, outcome measures, or analysis.
Discussing the need for, and management of, genetic testing for inherited cancer risk with individuals and their families can 
be challenging. As genetic testing in breast cancer becomes more common, the provision of specific communication-based 
training programs, with reference to genetic testing, risk assessments, and counseling skills is warranted.
Keywords Breast cancer · Communication · Education · Genetic counseling · Genetic testing · Systematic review
Introduction
A generally greater uptake of cancer risk assessments, avail-
ability of direct-to-consumer tests, and growing insurance 
coverage for these services has led to increasing demand for 
genetic services [1, 2]. This is particularly evident regarding 
hereditary breast cancer, which reportedly comprises ≈5% 
of all breast cancer presentations, and where BRCA1 and 
2 mutations put an individual at higher individual risk of 
additional cancers [3–6].
The call for accessible genetic services has grown expo-
nentially since the identification of BRCA1 (1994) and 
BRCA2 genes (1995). Furthermore, publicity surround-
ing high-profile celebrity cases (e.g., Angelina Jolie) sig-
nificantly increased public awareness of the genetic risk to 
cancer [3, 7–9]. However, such demand generally exceeds 
the availability of counseling services [9–11]. Consequently, 
many different healthcare providers (HCPs) may be involved 
in discussions about the need for genetic testing, the con-
sequences of a test result for an individual, and the ensu-
ing implications for other family members [10]. Genetic 
counselors or geneticists, primary care physicians making 
genetic referrals, specialist breast care nurses, oncologists, 
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or surgeons may all have a significant role in explaining the 
issues surrounding testing with individuals and their families 
[3, 5, 8, 12, 13]. The timing and format of these conver-
sations can impact the value they have for individuals and 
the overall health system [4]. For example, a primary care 
physician conducting an early risk assessment appropriately 
for someone worried about their own risk might well be 
sufficient and ease the pressure on genetic services [3, 14].
Providing genetic risk assessment, testing, and counseling 
necessitates an appropriate knowledge base and good com-
munication skills [15] including the ability to build rapport, 
while providing a clear explanation of risk, empathy, and 
a genuinely client-centered approach [16–18]. Rather than 
being prescriptive, the counselor needs to provide guidance 
and support thereby reinforcing an individual’s autonomy 
[19].
Genetic counseling has historically consisted of two main 
components, a pre- and post-test discussion. The pre-test 
session outlines information about the test and its outcomes, 
the provision of informed consent, and a discussion about 
family history and risk assessment [20–22]. If the patient 
proceeds with testing, the post-test session builds on pre-
test information while providing the test result itself [20]. 
Some patients may decline testing or there may not be a 
clinical need to proceed. Other methods of counseling are 
being used to provide services for a growing population with 
geographical diversity, such as telephonic sessions, group 
introductions, and pre- and post-test sessions delivered by 
different health professionals (e.g., a genetic counselor only 
seeing high-risk patients for a post-test consultation) [23].
Individual responses to test results vary, be they posi-
tive, negative, or a variant of uncertain significance (VUS). 
Effective counseling should then pre-empt and prepare a 
counselee for each of these outcomes with appropriate psy-
chosocial support [17, 21]. In order to do this, HCPs need 
commensurate levels of genetic knowledge and interper-
sonal skills to help an individual navigate complex ethical, 
familial, and legal issues [5, 24]. Not only do individuals 
have varying information needs, but HCPs need to be able 
to interpret and clearly convey the risk information, and cor-
responding referral and management options [19, 20, 25, 
26]. Consultations that are vague, overly complex, jargon-
istic, or are dominated by the clinician are deemed the most 
unsatisfactory [19, 26, 27]. Both members of the public and 
HCPs may have poor numeracy and struggle to understand 
risk-based information [19, 28]. This confusion can prohibit 
engagement and lead to conversations that result in misin-
formed decision making [15, 26]. Communication should 
then be both process and content-focused, providing correct 
information with relevant interpersonal skills.
These conversations play an important role in informing 
not only an individual’s own choices about treatment and 
surveillance, but potentially those of other members of their 
family [4, 7, 29–31]. Unfortunately, there is evidence that 
HCPs without specific genetic training often lack confidence 
and knowledge about the referral pathway, the genetic back-
ground of inheritance, or how to speak to individuals about 
genetic testing and risk assessment [11, 24, 32–34]. There 
are also concerns that without appropriate guidance, indi-
viduals may struggle to manage the psychological burden 
of testing and the future implications of any results [4, 35].
There has been considerable research around aids and 
interventions for the counselee [5, 24, 30, 36], along with 
exploration of the genetic counseling process and dialogue 
[18, 37]. However, training interventions directed at HCPs 
communicating risk and genetic based information are rare 
and less well evaluated.
Our systematic review examined the published literature 
to identify if, and how, communication skills were being 
included in educational materials for HCPs discussing 
hereditary breast cancer. As noted, good communication 
involves both process and content-based work. Reference 
to ‘communication skills’ within this paper then refers to 
a combination of both. Understanding this landscape can 
inform future training programs as a broader group of HCPs 
become involved in conversations about genetic testing for 
hereditary mutations relevant to breast cancer risk.
Methods
The review is registered on the PROSPERO database 
(CRD42019124010) and was conducted following the Pre-
ferred Reporting Items for Systematic Review and Meta-
analyses (PRISMA) statement.
Our specific objectives were to (a) identify published edu-
cational interventions available for HCPs discussing genetic 
testing in relation to breast cancer risk, (b) understand the 
components that make up these programs, including how 
communication skills were operationalized/defined, and (c) 
synthesize reported outcomes of intervention efficacy as 
dictated by the programs themselves. We consider ‘HCP’ 
to include genetic counselors/geneticists, medical students, 
nurses, oncologists, primary care providers (PCPs), and 
surgeons. This array of disciplines allows for the evolving 
model of HCPs who might conduct genetic conversations. 
We did not specify a control arm as the emphasis for this 
review was to understand the current landscape of available 
materials. We anticipated studies to report on outcomes such 
as HCP confidence and competence along with including 
their own working model or definition of communication 
skills.
Breast Cancer Research and Treatment 
1 3
Eligibility
Studies were included if they were published between 1995 
and February 2019, with the earlier parameter selected in 
line with the discovery of the BRCA genes. We anticipated 
a small and disparate body of literature and as such were 
deliberately inclusive in our criteria to maximize the number 
of eligible studies identified; papers were eligible if they 
reported an educational intervention conveying genetic 
information. These studies did not have to report solely on 
testing within breast cancer, as they could be embedded 
within a larger suite of training. However, they did need 
to directly reference breast cancer genetic material. We 
also included papers discussing the development of these 
interventions.
We excluded studies that purely reported population-
based testing or outcomes, including patient or public under-
standing of genetic testing, and those that only discussed 
analytic components of an assay or clinical outcomes associ-
ated with genetic test results, e.g., chemotherapy outcomes. 
Finally, we omitted papers that aimed to educate the public 
or patients on genetic testing, did not include any informa-
tion relevant to hereditary breast cancer, were not available 
in English, or were conference abstracts/letters/editorials.
Procedure
Our search terms were grouped into four categories for 
healthcare professionals, communication, interventions, and 
the population (Supplement 1).
Terms were combined with Boolean operators and 
searched using EMBASE, CINAHL, PUBMED, and Psy-
cINFO. Searches were saved into an EndNote X7 library and 
duplicates were removed using the in-built feature, coupled 
with a hand search.
Once duplicates were removed, titles and abstracts were 
screened by two authors (RS, VS) for relevance. The remain-
ing items were independently screened for their eligibility 
before confirming the final selection of papers for forward 
and backward searching. Those articles identified through 
forward/backward citation searching were confirmed against 
the eligibility criteria before being added to the final selec-
tion (Fig. 1).
Analysis
Data were extracted by one author (RS) and reviewed both 
for accuracy and completeness by a second (VS). The type of 
data extracted captured basic information about the article, 
the population, participant retention, the intervention itself 
including methods used, and the overall results.
Quality assessment was carried out for each study 
using the Effective Public Health Practice Project Quality 
Assessment Tool for Quantitative Studies (EPHPP) [38]. 
This tool was selected for its use in public health, with less 
reliance on statistical outcomes. The assessment comprised 
six components (selection bias, study design, confounders, 
blinding, data collection method, and withdrawals/dropouts), 
which were scored as ‘weak’, ‘moderate’, or ‘strong’. Papers 
were given a global rating using the same scale. While the 
review outcomes focused on intervention content, having a 
quality assessment tool allowed for standardized compari-
sons to be made across papers. Two reviewers (RS/VS) com-
pleted these assessments independent of one another before 
discussing and confirming global ratings.
Results
The initial search returned 3,988 items, of which 1,588 
were duplicates. The remaining 2,400 papers were reviewed 
by title and abstract for relevance, with eight items then 
screened against eligibility criteria. Of these, three were 
found to be pertinent with a further four identified through 
subsequent forward and backward citation searching. Seven 
papers meeting the inclusion criteria were included with two 
linked publications, reporting on the same study but focus-
ing on different outcomes [39, 40]. These will be referred 
to separately for the purposes of discussing methods and 
outcomes.
Sample characteristics
The final seven papers involved a range of HCP audiences, 
including PCPs [39–41], nurses [42–44], physicians [42, 
43], genetic counselors [42], and medical students [45]. 
Three (four papers) of the six interventions used a rand-
omized study design [39–41, 44]. Table 1 summarizes the 
extracted data from each study.
Intervention characteristics
One intervention utilized a web-based platform [39, 40], 
with the remaining five adopting face-to-face approaches 
[41–45] of traditional lecture formats [41–45], counseling 
role play scenarios [41–44], risk assessment practice 
[42–44], lab experience [42], patient discussions [41], and 
mentorship [44].
The training focused on topics such as communication/
counseling skills [39–45], genetic testing principles [39, 40, 
42–45], psychosocial and ethical, legal, and social issues 
(ELSI) [39, 40, 43–45], hereditary cancers/BRCA [41–43, 
45], and risk assessment [39, 40, 44].
Interventions provided face-to-face were either completed 
in one day [41], over multiple days up to two weeks [42–44], 
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or a longer expanse of time [45]. The web-based intervention 
took six hours to complete [39, 40].
Outcomes
Across the papers, the most common outcome assessed was 
communication skills but there was a lack of specificity as to 
what this comprised [39–41, 43, 45]. There was an inconsist-
ency as to whether communication outcomes referenced pro-
cess work or the correct dissemination of information. For 
those studies that used standardized patients (SPs) to assess 
candidate performance, both elements of communication 
skills were referenced [39, 40, 45]. In one intervention, 
counseling skills were assessed before and after the training 
using a knowledge test, including items about the compe-
tences required during counseling and for disclosure of test 
results. Skills relating to counseling prior to genetic testing 
significantly improved, while those concerning test results 
significantly decreased post intervention [43]. While practice 
sessions were included within the intervention, there was 
an absence of information as to the specific communication 
elements imparted. Other studies captured communication 
skills via knowledge or efficacy measures, again without 
clear detail on content [42, 44].
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Self-efficacy and confidence were reported as outcomes 
in four studies [40, 43–45]. This was sometimes described 
as confidence in counseling practice [43] or clinical skills 
efficacy [40]. In other studies, self-efficacy was broadened 
to include concepts such as assessing risk, drawing a pedi-
gree, obtaining a medical history, interpreting results, and 
discussing screening [44, 45]. In general, self-efficacy scores 
significantly improved between pre and post intervention 
[40, 43–45]. Two papers with a comparator arm [40, 45] 
reported significant between group differences; however, 
only one reported post-intervention scores for both groups 
rendering it impossible to assess the true impact of the inter-
vention [45].
Similarly, knowledge was assessed in four studies with 
tests covering topics such as genetic testing, shared decision 
making, ELSI, cancer genetics, and hereditary syndromes 
including breast cancer [40, 42, 43, 45]. One study compared 
knowledge scores pre and post attendance in both the inter-
vention and control arms [40]. While neither arm improved 
on shared decision making, both had significant improve-
ments in overall knowledge and subsets of BRCA genetics, 
breast cancer, and ELSI, with further significant improve-
ments in the intervention arm for understanding genetic test 
ordering and general genetics. Two papers report significant 
gains in overall knowledge [42] [43]. One further study used 
a knowledge test but did not provide the scores within the 
current paper [45].
Four papers reported participant satisfaction with the 
training program [40–42, 45], often evaluated at the end of 
the program apart from one that assessed clarity of instruc-
tion, realism, and overall usefulness following each SP visit 
[45]. In another study, 95% of participants cited continued 
use and benefit from the course material [42]. A further 
paper noted that 12/35 attendees completed course feedback; 
most wanted more counseling practice with six individuals 
highlighting the importance of communication skills [43].
Quality assessment
All studies were given a ‘weak’ global rating on the EPHPP 
(two or more of the six categories scored as ‘weak’), though 
studies did receive some ‘moderate’ and ‘strong’ scores in 
individual categories. No study outlined randomization pro-
cedures. Only one received a ‘moderate’ score for selection 
bias as there was enough information to assume the inter-
vention group were similar to the target population [45]. 
Two studies reported group differences, or confounders, 
between the intervention and comparator at baseline [40, 
41]. Another two described both the reliability and validity 
of their measures [40, 42], with reliability mentioned in a 
further two reports [39, 43] and validity by one other [41].
The quality assessment for drop-out and withdrawal rates 
presented a range of scores with three papers receiving a 
‘weak’ rating due to a lack of transparency of baseline num-
bers or low completion rates [41, 42, 45], three a ‘moderate’ 
rating owing to the amount of drop outs [39, 40, 44], and one 
paper received a ‘strong’ rating [43].
Discussion
This systematic review identified seven published papers 
featuring six interventions provided to HCPs communicat-
ing risk-based information about hereditary breast cancer. 
The participants were various groups of HCPs but primarily 
PCPs [39–41] and nurses [42–44]. The use of SPs was prom-
inent across interventions to simulate that of a real clinical 
encounter. This provided participants with an opportunity to 
practice counseling skills, often resulting in improved self-
reported efficacy and confidence. Within those studies that 
reported participant satisfaction, it was clear that individuals 
felt they had benefitted from their training and were keen to 
engage with more materials.
There was however a lack of detail about the specific 
communication behaviors included in training. From the 
descriptions provided, it was unclear how much the studies 
discussed the content of what to include in conversations 
versus the process of conveying that information. In line 
with genetic counseling models, which we used to inform 
our understanding of which communication skills were most 
likely to be included in training courses, we anticipated 
reference to both the correct dissemination of information 
alongside interpersonal skills such as empathic understand-
ing and chunking and checking information [15, 20, 21, 23]. 
Successful genetic counseling conversations require not only 
an ability to explain risk in a manner that aids understand-
ing but also rapport and empathy [15, 18]. Consultations 
should therefore incorporate components of genetic coun-
seling, education, and psychosocial well-being [21]. While 
these topics may have been covered within the educational 
programs, they were not specifically referenced or reported. 
This review set out to understand the communication ele-
ments within HCP training programs, particularly the pres-
ence of both process and content-based skills. However, a 
lack of clear definition within the studies precluded a true 
assessment of their presence and impact.
Given the implications of genetic conversations, there is 
a need for interventions which address HCP confidence and 
skill when navigating these complex issues [5, 29, 31, 32]. 
This is especially true as more responsibility is given to a 
wider population of HCPs to engage in this dialogue. There 
was a dearth of reported interventions for oncologists or sur-
geons who may be the first point of contact for an individual. 
Previous systematic reviews have been conducted looking at 
groups of HCPs in isolation, such as PCPs [46]. However, as 
genetic consultations are being carried out in various ways, 
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and often with different types of clinician working together 
(e.g., oncologist and geneticist), the focus in this review was 
on clinicians as a whole to reflect this changing landscape 
and a diverse MDT [23]. In addition, the lack of relevant 
published papers, and the overall weak quality scores, in this 
review indicates a need for robust evaluation of these train-
ing programs built on recommendations from the genetic 
counseling field.
Research recommendations
A lack of definition across the studies for what constituted 
counseling skills demonstrates a need for future research to 
clearly operationalize this concept from the outset. There is a 
clear need for future training and assessment to focus on the 
process of communication [16, 19]. Our results suggest this 
could be beneficial as it was not clear from the interventions 
whether or not ‘good’ communication was characterized 
solely by the correct transmission of factual information or 
the actual process and engagement. The use of a framework 
or inclusion of specific communication tools would add clar-
ity to what is currently an ambiguous understanding.
The psychosocial support provided to individuals dur-
ing a genetic consultation is just as important as knowledge 
exchange [18, 20, 26] yet only two studies reported on a 
general lack of discussion between HCP and SP about these 
concerns [40, 45]. As these elements are a key feature of 
risk-based testing and decision making, it is important for 
future work to be more explicit as to how training targets the 
ability to communicate in this way.
While the client–HCP interaction is paramount, it is 
also necessary to explore interdisciplinary communication. 
This is especially so as more genetic testing information is 
provided via a team approach. While our findings demon-
strate training materials are available, we did not identify 
any published interventions that were available for multi-
disciplinary teams (MDTs). For example, genetic referral 
pathways may include surgical, nursing, and oncology input 
and yet training was not available in one setting, which can 
help ensure consistent communication. To that end, we have 
secured funding to develop a training program in this area, 
which will be informed by this systematic review.
Practice implications
While the predominant outcomes of this review relate to 
future research, there are still practice implications to be 
gleaned. With a lack of published training targeting a com-
plete MDT, it is important for colleagues to work together 
to understand how genetic information is being relayed to 
avoid confusion or contradiction.
This review suggests that some studies convey measurable 
benefits for HCPs, many of whom desire to undertake further 
counseling training. More evidence-based interventions may 
then assist HCPs when talking with individuals who poten-
tially carry gene mutations.
Study limitations
We identified only those papers published in peer-reviewed 
journals and there may be further information in gray literature 
and conference abstracts/editorials/letters. Our focus on pub-
lished material was to understand the training programs which 
had been evaluated in some way. There may be other interven-
tions available for HCPs that have gone unreported. In hind-
sight there may have been limitations to using the EPHPP tool. 
While this is a good quality assessment measure, the nature of 
the papers inherently leant themselves to receive lower scores 
primarily due to non-randomization and lack of control arms. 
However, we felt it was important to use a tool to help stand-
ardize our assessments without prior knowledge of the types 
of studies our searches would find.
Conclusion
This systematic review set out to explore what published train-
ing interventions were available for HCPs discussing genetic 
testing and hereditary risk for breast cancer. This process 
demonstrated a lack of formally evaluated training programs. 
All seven papers reported on communication outcomes with 
particular use of an SP. Other outcomes such as knowledge, 
confidence/self-efficacy, and program satisfaction were cap-
tured. However, what is evident is a lack of consistent training 
materials used, with demonstrable paucity of support specifi-
cally for oncologists/surgeons.
There is increasing demand for genetic services within 
breast cancer, either to identify inherited risk or to personalize 
treatment options. In response to this, there is a commensurate 
need to ensure those HCPs tasked with helping individuals 
navigate the complex world of genetic breast cancer testing are 
well versed in conveying risk-based information.
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